Live tape
Top 8, mentions 7d16,280NVDA5,928 mentions▲ +0.04GOOGL2,220 mentions▲ +0.05SPY1,854 mentions▲ +0.05QQQ1,660 mentions▲ +0.05AMD1,342 mentions▲ +0.08SPCX1,342 mentions▲ +0.05TSLA1,029 mentions▲ +0.05MSFT905 mentions▲ +0.04

Equity · Healthcare

ASND

NASDAQ

Ascendis Pharma A/S (ASND)

259.78 USD +1.17% vs prior close Nov 9, 2026
Ascendis Pharma A/S price graph
63 sessions
280 220 12 Aug 9 Nov

The line runs 255 USD on 12 August through 259.78 USD on 9 November, on a scale from 220 to 280. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView
52-week range
196 USD – 277 USD
Avg volume
48.5K

as of Nov 9, 2026

Have Ascendis Pharma A/S (ASND) insiders bought or sold shares recently?

In the 90 days to 11 Nov 2026, Ascendis Pharma A/S insiders reported 2 open-market sales and 1 purchase (SEC Form 4).

Form 4, 90 days to 11 Nov 2026, newest reported trade 8 Sep 2026

1buys
2sells
$380Knet sold
1other filings
Have Ascendis Pharma A/S (ASND) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
08 Sep 2026Bodenhoff MadsSVP & PAOSell3,000811K USD
02 Sep 2026HOLTUG LARSDirectorSell23662K USD
14 Aug 2026BIENAIME JEAN JACQUESDirectorBuy2,000493K USD
Bought1 open-market purchase2,000$493K
Sold2 open-market sales3,236$873K
1 other filing in the window: a grant, exercise, tax withholding or transfer, not a trade
Have Ascendis Pharma A/S (ASND) insiders bought or sold shares recently?
ReportedInsiderTypeSharesValue
08 Sep 2026Bodenhoff MadsSVP & PAOOption exercise3,000330K USD

Which funds hold Ascendis Pharma A/S (ASND)?

8 of the 45 institutional funds we track reported a Ascendis Pharma A/S position for the quarter ended 30 Jun 2026 — a combined 248.4M USD; the latest of those filings landed 02 Sep 2026.

Form 13F

Which funds hold Ascendis Pharma A/S (ASND)?
FundPositionSharesValueShares q/q
Two Sigma InvestmentsNew position305,80381.6M USD
Millennium ManagementNew position266,70871.1M USD
Citadel AdvisorsNew position137,88936.8M USD
Renaissance TechnologiesNew position119,69931.9M USD
Balyasny Asset ManagementNew position31,0238.3M USD
D. E. Shaw & Co.New position30,8838.2M USD
Marshall WaceNew position22,5036.0M USD
Tudor Investment CorpNew position16,6254.4M USD
AQR Capital ManagementExited
D. E. Shaw & Co.Exited

Have members of Congress traded Ascendis Pharma A/S (ASND)?

The most recent congressional trade disclosed in Ascendis Pharma A/S is a purchase by Gary J. Palmer (house, AL), dated 12 Jul 2018.

STOCK Act disclosures

Have members of Congress traded Ascendis Pharma A/S (ASND)?
TradedMemberTypeAmountFiled after
12 Jul 2018Gary J. Palmerhouse · Republican–ALPurchase1K USD–15K USD79 days

What has been filed or recorded for Ascendis Pharma A/S (ASND)?

The filings we hold for Ascendis Pharma A/S, newest first: 4 fails-to-deliver days, the latest dated 13 Oct 2026.

What has been filed or recorded for Ascendis Pharma A/S (ASND)?
And
13 Oct 2026Fails to deliverShares failed to deliver22 shares5K USD notional · <0.001% of shares out
09 Oct 2026Fails to deliverShares failed to deliver26 shares6K USD notional · <0.001% of shares out
08 Oct 2026Fails to deliverShares failed to deliver1,201 shares274K USD notional · 0.002% of shares out
28 Sep 2026Fails to deliverShares failed to deliver1,158 shares261K USD notional · 0.002% of shares out

What do people ask about Ascendis Pharma A/S (ASND)?

From live data
What did Ascendis Pharma A/S shares close at?259.78

Ascendis Pharma A/S closed at 259.78 USD on 9 Nov 2026, up 1.17% on the close before. That is the end-of-day price from Finazon, not a live quote.

Have Ascendis Pharma A/S insiders bought or sold shares recently?2 sales

In the 90 days to 11 Nov 2026, Ascendis Pharma A/S insiders reported 2 open-market sales and 1 purchase (SEC Form 4). A further 1 filing was a grant, award, gift or exercise rather than an open-market trade. See Insiders

Which funds own Ascendis Pharma A/S?8 of 45

8 of the 45 funds we track reported a Ascendis Pharma A/S position for the quarter ended 30 Jun 2026, per their SEC Form 13F filings. The largest reported positions were Two Sigma Investments, Millennium Management and Citadel Advisors. See Funds

Have members of Congress traded Ascendis Pharma A/S?1 trade

Yes. 1 trade in Ascendis Pharma A/S appears in the congressional disclosures we hold: a purchase by Gary J. Palmer (House, AL) dated 12 Jul 2018, filed 29 Sep 2018. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress

Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.

References
  1. Finazonprior-day close, indicative (IEX-derived, not the official close), most closes dollar-rounded at the source
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARForm 4 filings (insider transactions)
  4. SEC EDGAR13F filings
  5. Wikimedia CommonsPortraits via Wikimedia Commons. Gary J. Palmer: United States Congress, Public domain.
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SECSEC fails-to-deliver (CNS) data